ホスホジエステラーゼ4
- 関
- PDE4、type 4 cyclic nucleotide phosphodiesterase
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/08/27 01:00:50」(JST)
[Wiki en表示]
Two types of the enzyme phosphodiesterase 4 (PDE4) are known:
- PDE4A
- PDE4B
- 3',5'-cyclic-AMP phosphodiesterase
See also
- Phosphodiesterase
- PDE4 inhibitor
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Role of phosphodiesterase-4 on ethanol elicited locomotion and narcosis.
- Baliño P1, Ledesma JC2, Aragon CM3.
- Neuropharmacology.Neuropharmacology.2016 Feb;101:271-8. doi: 10.1016/j.neuropharm.2015.10.001. Epub 2015 Oct 9.
- The cAMP signaling pathway has emerged as an important modulator of the pharmacological effects of ethanol. In this respect, the cAMP-dependent protein kinase has been shown to play an important role in the modulation of several ethanol-induced behavioral actions. Cellular levels of cAMP are maintai
- PMID 26449868
- Electropharmacogram of Sceletium tortuosum extract based on spectral local field power in conscious freely moving rats.
- Dimpfel W1, Schombert L2, Gericke N3.
- Journal of ethnopharmacology.J Ethnopharmacol.2016 Jan 11;177:140-7. doi: 10.1016/j.jep.2015.11.036. Epub 2015 Dec 1.
- ETHNOPHARMACOLOGICAL RELEVANCE: The endemic succulent South African plant, Sceletium tortuosum (L.) N.E. Br. (synonym Mesembryanthemum tortuosum L.), of the family Mesembryathemaceae, has an ancient oral tradition history of use by San and Khoikhoi people as an integral part of the indigenous cultur
- PMID 26608705
- Management of Behçet's syndrome.
- Ozguler Y1, Hatemi G.
- Current opinion in rheumatology.Curr Opin Rheumatol.2016 Jan;28(1):45-50. doi: 10.1097/BOR.0000000000000231.
- PURPOSE OF REVIEW: Current trends in the management of Behçet's syndrome will be reviewed in this article.RECENT FINDINGS: Biologic agents have gained increasing importance over the years in the management of Behçet's syndrome. Long-term results of observational studies have shown that anti-tumor
- PMID 26555450
Japanese Journal
- IPFに合併する二次性肺高血圧症の管理 (特集 特発性肺線維症の併存症・合併症とどう向き合うか)
- cGMP制御を介したPDE5阻害薬の心肥大抑制機序
- ED,持続勃起症の治療 (シンポジウム 西日本におけるアンドロロジー)
- 西日本泌尿器科 = The Nishinihon journal of urology 77(6), 207-211, 2015-06
- NAID 40020496756
Related Links
- phosphodiesterase、PDE 細胞内セカンドメッセンジャーであるサイクリックAMP (cAMP)およびサイクリックGMP (cGMP)を分解しそれぞれ5’-AMP, 5’-GMPとする酵素。cAMP、cGMPのシグナル伝達を調節しており、哺乳類では11種類の ...
- Phosphodiesterase-4 isoenzymes have absolute specificity for cyclic adenosine-3′,5′-monophosphate and are considered potential therapeutic targets for the treatment of chronic inflammatory disorders, such as chronic obstructive ...
★リンクテーブル★
[★]
- 英
- phosphodiesterase 4、PDE4
- 関
- 4型サイクリックヌクレオチドホスホジエステラーゼ
[★]
4型サイクリックヌクレオチドホスホジエステラーゼ
- 関
- phosphodiesterase 4
[★]
- 関
- phosphodiesterase 4
[★]
ホスホジエステラーゼ PDE
[★]
ホスホジエステラーゼ